<p>C57BL/6 mice were sensitized with an intraperitoneal (i.p.) injection of 50 μg ovalbumin and 25 μg Alum on days 0 and 12. On days 22, 26 and 30, mice were challenged with 2% OVA aerosol (w/v) in saline (Neb) for 30 min. For treatments, 1x10<sup>7</sup> of CIK cells, PBS or thymocytes were transferred via tail vein on day 21, and 2mg/kg/day dexamethasone was injected i.p. from day 21 to 30. All mice were evaluated 24 h after last challenge.</p
<p>For sensitization, BALB/c mice received an i.p injection of OVA or PBS with aluminum hydroxide on...
The effectiveness of cytokine-induced killer (CIK) cells for treatment of cancers has long been appr...
OVA-sensitized mice were administered PBS or anti-CCL20 antibody (20 μg/mouse) via i.p. injection be...
<p>Mice were sensitised to OVA by three intraperitoneal (i.p.) injections on days 0, 14 and 21 with ...
<p>Mice were exposed to an OVA “sensitization plus challenge” protocol. In <b>A</b>, the schedule an...
<p>Diagrammatic representation of the sensitization and challenge protocols to induce allergic lung ...
<p>At 8 weeks of age, male and female mice were sensitized intraperitoneally with either 0.02 µg ova...
<p>Group 1: ovalbumin (OVA)-sensitized mice injected intraperitoneally with 10 µg of OVA plus 4 mg o...
<p>Mice were sensitized by two injections of OVA/alum and challenged by exposure to aerosols of alle...
<p>The OVA-sensitized and challenged group: mice were sensitized on days 1, 3, 5, 7, 9, 11 and 13 by...
<p>(A) Schematic representation of the protocol for OVA sensitization, influenza virus infection, an...
<p>Sensitization and challenge protocol for an ovalbumin-induced mouse asthma model.</p
<p>(A) Schematic illustration of the inflammatory airway disease model; (B-D) WT mice were injected ...
<p>Mice were treated with recombinant TRAIL before OVA challenges and the cellular influx in the BAL...
<p>OVA, ovalbumin; OVA/Alum, ovalbumin/aluminum hydroxide; i.p., intraperitoneal injection; GGTA, Gu...
<p>For sensitization, BALB/c mice received an i.p injection of OVA or PBS with aluminum hydroxide on...
The effectiveness of cytokine-induced killer (CIK) cells for treatment of cancers has long been appr...
OVA-sensitized mice were administered PBS or anti-CCL20 antibody (20 μg/mouse) via i.p. injection be...
<p>Mice were sensitised to OVA by three intraperitoneal (i.p.) injections on days 0, 14 and 21 with ...
<p>Mice were exposed to an OVA “sensitization plus challenge” protocol. In <b>A</b>, the schedule an...
<p>Diagrammatic representation of the sensitization and challenge protocols to induce allergic lung ...
<p>At 8 weeks of age, male and female mice were sensitized intraperitoneally with either 0.02 µg ova...
<p>Group 1: ovalbumin (OVA)-sensitized mice injected intraperitoneally with 10 µg of OVA plus 4 mg o...
<p>Mice were sensitized by two injections of OVA/alum and challenged by exposure to aerosols of alle...
<p>The OVA-sensitized and challenged group: mice were sensitized on days 1, 3, 5, 7, 9, 11 and 13 by...
<p>(A) Schematic representation of the protocol for OVA sensitization, influenza virus infection, an...
<p>Sensitization and challenge protocol for an ovalbumin-induced mouse asthma model.</p
<p>(A) Schematic illustration of the inflammatory airway disease model; (B-D) WT mice were injected ...
<p>Mice were treated with recombinant TRAIL before OVA challenges and the cellular influx in the BAL...
<p>OVA, ovalbumin; OVA/Alum, ovalbumin/aluminum hydroxide; i.p., intraperitoneal injection; GGTA, Gu...
<p>For sensitization, BALB/c mice received an i.p injection of OVA or PBS with aluminum hydroxide on...
The effectiveness of cytokine-induced killer (CIK) cells for treatment of cancers has long been appr...
OVA-sensitized mice were administered PBS or anti-CCL20 antibody (20 μg/mouse) via i.p. injection be...